(S (PP (IN With) (NP (NP (DT the) (JJ rapid) (NN development)) (PP (IN of) (NP (NML (JJ high) (HYPH -) (NN throughput)) (NNS technologies))))) (, ,) (NP (NP (JJ parallel) (NN acquisition)) (PP (IN of) (NP (NP (NML (JJ large) (HYPH -) (NN scale)) (NN drug) (HYPH -) (NNS informatics)) (NP (NNS data))))) (VP (VBZ provides) (NP (JJ huge) (NNS opportunities)) (S (VP (TO to) (VP (VB improve) (NP (JJ pharmaceutical) (NN research) (CC and) (NN development)))))) (. .))
(S (NP (CD One) (JJ significant) (NN application)) (VP (VBZ is) (NP (NP (NP (DT the) (NN purpose) (NN prediction)) (PP (IN of) (NP (JJ small) (NN molecule) (NNS compounds)))) (, ,) (VP (VBG aiming) (S (VP (VP (TO to) (VP (VB specify) (NP (NP (JJ therapeutic) (NNS properties)) (PP (IN of) (NP (JJ extensive) (ADJP (NN purpose) (HYPH -) (JJ unknown)) (NNS compounds)))))) (CC and) (VP (TO to) (VP (VB repurpose) (NP (NP (JJ novel) (JJ therapeutic) (NNS properties)) (PP (IN of) (NP (ADJP (NNP FDA) (HYPH -) (VBN approved)) (NNS drugs))))))))))) (. .))
(S (NP (JJ Such) (NN problem)) (VP (VBZ is) (ADJP (RB very) (JJ challenging)) (SBAR (IN since) (S (NP (NN compound) (NNS attributes)) (VP (VBP contain) (NP (JJ heterogeneous) (NNS data)) (PP (IN with) (NP (NP (JJ various) (NN feature) (NNS patterns)) (PP (JJ such) (IN as) (NP (NML (NML (NN drug) (NN fingerprint)) (, ,) (NML (ADJP (NN drug) (JJ physicochemical)) (NN property)) (, ,) (NML (NN drug) (NN perturbation))) (NN gene) (NN expression))))))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (JJ complex) (JJ nonlinear) (NN dependency)) (PP (IN among) (NP (JJ heterogeneous) (NNS data))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP propose) (S (NP (NP (DT a) (JJ novel) (NN domain)) (HYPH -) (NP (JJ adversarial))) (VP (VB multi-task) (NP (NN framework)) (PP (IN for) (S (VP (VBG integrating) (NP (VBN shared) (NN knowledge)) (PP (IN from) (NP (JJ multiple) (NNS domains))))))))) (. .))
(S (NP (DT The) (NN framework)) (VP (VBZ utilizes) (NP (DT the) (JJ adversarial) (NN strategy)) (S (VP (TO to) (ADVP (RB effectively)) (VB learn) (NP (NN target) (NNS representations) (CC and) (NNS models)) (NP (PRP$ their) (JJ nonlinear) (NN dependency))))) (. .))
(S (NP (NP (NNS Experiments)) (PP (IN on) (NP (CD two) (NML (JJ real) (HYPH -) (NN world)) (NNS datasets)))) (VP (VBP illustrate) (SBAR (IN that) (S (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (PRP$ our) (NN approach)))) (VP (VBZ obtains) (NP (NP (DT an) (JJ obvious) (NN improvement)) (PP (IN over) (NP (JJ competitive) (NNS baselines)))))))) (. .))
(S (NP (NP (DT The) (JJ novel) (JJ therapeutic) (NNS properties)) (PP (IN of) (NP (NP (ADJP (NN purpose) (HYPH -) (JJ unknown)) (NNS compounds)) (SBAR (S (NP (PRP we)) (VP (VBD predicted))))))) (VP (VBP are) (ADVP (RB mostly)) (VP (VBN reported) (CC or) (VBN brought) (PP (IN to) (NP (DT the) (NNS clinics))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP (PRP$ our) (NN framework)) (VP (VP (MD can) (VP (VB integrate) (NP (JJ various) (NNS attributes)) (PP (IN beyond) (NP (NP (DT the) (CD three) (NNS domains)) (VP (VBN examined) (ADVP (RB here))))))) (CC and) (VP (MD can) (VP (VB be) (VP (VBN applied) (PP (IN in) (NP (DT the) (NN industry))) (PP (IN for) (S (VP (VBG screening) (NP (NP (DT the) (NN purpose)) (PP (IN of) (NP (NP (JJ huge) (NNS amounts)) (PP (IN of) (NP (ADJP (ADVP (RB as) (RB yet)) (JJ unidentified)) (NNS compounds))))))))))))) (. .))
(S (NP (NP (NN Source) (NNS codes)) (PP (IN of) (NP (DT this) (NN paper)))) (VP (VBP are) (ADJP (JJ available) (PP (IN on) (NP (NNP Github))))) (. .))
